https://www.ophthalmologytimes.com/view/gene-therapy-offers-first-steps-in-treatment-of-achromatopsia 2021-07-07 0.50 https://www.ophthalmologytimes.com/view/foveal-morphologic-changes-in-lca-sparked-by-gene-therapy 2021-07-07 0.50 https://www.ophthalmologytimes.com/view/analysis-24-month-data-paladin-study 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/real-world-trial-data-replication-outcomes-iris-registry-data 2021-05-04 0.50 https://www.ophthalmologytimes.com/view/linking-patient-imaging-to-aao-iris-registry-data 2021-05-04 0.50 https://www.ophthalmologytimes.com/view/analyzing-clinical-results-dexamethasone-implant-effect-macular-thickness 2021-07-13 0.50 https://www.ophthalmologytimes.com/view/diabetes-and-dr-progress-global-epidemic 2021-04-30 0.50 https://www.ophthalmologytimes.com/view/study-targeting-safety-efficacy-of-subretinal-gene-therapy-for-x-linked-retinitis-pigmentosa 2021-05-05 0.50 https://www.ophthalmologytimes.com/view/wet-amd-treatment-burden-eased-by-nonviral-gene-therapy 2021-05-03 0.50 https://www.ophthalmologytimes.com/view/novel-factors-predict-ocriplasmin-efficacy-symptomatic-vitreomacular-traction 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/targeting-neurodegenerative-diseases-risuteganib-treatment-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/faricimab-primary-study-endpoint-tenaya-lucerne-trials 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/intravitreal-injection-allogeneic-human-retinal-progenitor-cells 2021-04-28 0.50 https://www.ophthalmologytimes.com/view/timely-recognition-central-retinal-arterial-occlusions-key-patients 2021-04-27 0.50 https://www.ophthalmologytimes.com/view/examining-novel-factors-predict-ocriplasmin-efficacy-symptomatic-vitreomacular-traction 2021-04-27 0.50 https://www.ophthalmologytimes.com/view/research-anti-vegf-treatment-lapses-retinal-vein-occlusion 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/investigating-low-vulnerability-posterior-eye-segment-sars-cov-2 2021-04-30 0.50 https://www.ophthalmologytimes.com/view/ray-tracing-iol-modeling-amd-patients 2021-04-30 0.50 https://www.ophthalmologytimes.com/view/study-shows-positive-results-treatment-dme-faricimab 2021-05-04 0.50 https://www.ophthalmologytimes.com/view/making-the-case-for-nurses-to-inject-dexamethasone-implants 2021-08-12 0.50 https://www.ophthalmologytimes.com/view/arvo-2021-stage-set-for-revolutionary-eye-and-vision-research- 2021-04-25 0.50 https://www.ophthalmologytimes.com/view/together-strength-in-numbers-to-beat-childhood-visual-system-disorders 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/considering-yag-vitreolysis-for-persistent-vitreous-floaters 2021-04-22 0.50 https://www.ophthalmologytimes.com/view/q-a-the-increasing-potential-of-erg-in-diagnosing-a-wide-range-of-eye-conditions 2021-04-21 0.50 https://www.ophthalmologytimes.com/view/pearls-for-managing-diabetic-retinopathy-in-pediatric-patients 2021-04-19 0.50 https://www.ophthalmologytimes.com/view/how-gene-therapy-clinical-trials-are-addressing-retinal-diseases-at-the-core 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/confirming-uveitis-treatment-efficacy-in-study 2021-04-15 0.50 https://www.ophthalmologytimes.com/view/managing-uveitis-with-a-multidisciplinary-treatment-approach 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/multicolor-and-autofluorescence-imaging-coming-to-terms 2021-04-13 0.50 https://www.ophthalmologytimes.com/view/dme-study-efficacy-of-intravitreal-dexamethasone-implant-is-robust 2021-04-09 0.50 https://www.ophthalmologytimes.com/view/testing-hp-b-cd-as-potential-amd-therapy-with-cholesterol-lowering-capabilities 2021-04-09 0.50 https://www.ophthalmologytimes.com/view/how-telemedicine-is-forging-a-new-chapter-in-eye-care 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/iriss-registry-safety-study-offers-framework-for-real-world-dme-outcomes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/intraoperative-oct-seeking-a-new-frontier 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/5-ways-the-drcr-retina-network-is-reshaping-diabetic-eye-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/inherited-retinal-dystrophies-how-regeneration-may-help-restore-vision 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/casting-a-new-light-on-fundus-imaging 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/advm-022-sustained-anatomic-improvements-for-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/why-uveitis-is-a-leading-and-underestimated-cause-of-visual-morbidity-in-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-ophthalmologists-can-benefit-from-en-face-oct 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/medication-induced-retinal-toxicity-how-risk-awareness-can-help 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/strategies-for-managing-strabismus-after-repair-of-retinal-detachments 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2021-virtual-symposium-takeaways-and-final-thoughts 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/ang-2-vegf-a-inhibition-synergistic-effect-in-dme-and-amd 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/novel-options-continue-to-fill-sustained-drug-delivery-pipeline 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/subretinal-gene-therapy-for-neovascular-amd-showing-efficacy-and-safety 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/adapting-medical-retina-service-in-covid-19-era-requires-careful-approach 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/genetic-testing-raises-the-bar-for-retinal-disease-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/inherited-retinal-disease-gene-therapy-ushers-new-era 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/treatment-may-facilitate-sight-in-end-stage-retinitis-pigmentosa 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/shedding-light-on-health-care-disparities-among-us-patients 2021-03-12 0.50 https://www.ophthalmologytimes.com/view/in-home-self-monitoring-of-amd-patients-identifies-retinal-fluid 2021-03-11 0.50 https://www.ophthalmologytimes.com/view/pearls-for-optimizing-patient-outcomes-of-macular-surgery 2021-03-11 0.50 https://www.ophthalmologytimes.com/view/pilot-pregnancy-pathway-addresses-challenges-of-diabetic-retinopathy-screening 2021-02-26 0.50 https://www.ophthalmologytimes.com/view/updates-from-angiogenesis-2021 2022-01-05 0.50 https://www.ophthalmologytimes.com/view/emerging-therapies-in-management-of-amd 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/3-major-risk-factors-of-amd 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/amd-learning-the-basics 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/from-etdrs-to-evired-eyeing-a-new-artificial-intelligence-based-algorithm 2021-02-03 0.50 https://www.ophthalmologytimes.com/view/dme-strategies-directed-by-knowledge-of-mechanisms 2021-02-03 0.50 https://www.ophthalmologytimes.com/view/rift-in-the-retina-may-pave-way-for-repair-of-the-optic-nerve 2021-01-29 0.50 https://www.ophthalmologytimes.com/view/what-attendees-can-expect-at-the-2021-virtual-angiogenesis-meeting 2021-01-28 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2021-imaging-among-the-focal-points-for-february-12-agenda 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2021-february-13-agenda-takes-on-amd-dme-dr-gene-therapy 2021-01-29 0.50 https://www.ophthalmologytimes.com/view/the-state-of-dry-wet-amd-2021 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/ophthalmologist-shares-his-story-on-holocaust-remembrance-day 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/meiragtx-reports-fast-track-designation-by-fda-for-gene-therapy-candidate-to-treat-achm 2021-01-26 0.50 https://www.ophthalmologytimes.com/view/what-keeps-ophthalmologists-up-at-night-part-iii-mr 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/axitinib-injectable-suspension-phase-1-2a-trial-enrolls-first-patients 2021-01-12 0.50 https://www.ophthalmologytimes.com/view/amydis-announces-successful-pre-ind-meeting-with-fda-to-develop-retinal-tracer-for-amyloid-angiopathy-diagnosis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/saving-the-world-pharmaceutical-innovation-in-nine-months 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/evolving-clinical-practice-insights-gained-from-real-world-evidence 2022-05-24 0.50 https://www.ophthalmologytimes.com/view/navigating-real-world-evidence-in-ophthalmology 2022-05-24 0.50 https://www.ophthalmologytimes.com/view/conducting-an-audit-and-using-real-world-evidence-in-your-practice 2022-05-24 0.50 https://www.ophthalmologytimes.com/view/what-an-intravitreal-integrin-antagonist-may-bring-to-dme 2021-01-05 0.50 https://www.ophthalmologytimes.com/view/post-hoc-analysis-protocol-v-provides-more-practical-dme-guidance-for-clinicians 2021-01-05 0.50 https://www.ophthalmologytimes.com/view/safety-and-efficacy-of-kpi-121-0-25-for-ded-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/analyzing-an-investigational-ophthalmic-solution-for-treating-presbyopia-related-symptoms 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/evaluating-long-term-safety-of-micro-bypass-implant-phaco-in-pxg 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/violet-light-filtering-iols-visual-and-non-visual-benefits 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/drug-delivery-vs-drops-controlling-postop-pain-inflammation-in-cataract-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/optimizing-retinal-disease-management-in-real-world-clinical-practice 2020-12-02 0.50 https://www.ophthalmologytimes.com/view/single-administration-of-intracameral-bimatoprost-implant-iop-lowering-safety 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/emerging-agents-for-the-treatment-of-dr-dme 2021-08-10 0.50 https://www.ophthalmologytimes.com/view/impact-of-covid-19-on-management-of-dr-dme 2021-08-10 0.50 https://www.ophthalmologytimes.com/view/pandemic-s-impact-on-us-ophthalmology-patient-care-real-world-insights 2020-12-07 0.50 https://www.ophthalmologytimes.com/view/what-a-proposed-biosimilar-may-mean-for-subfoveal-wet-amd 2020-12-01 0.50 https://www.ophthalmologytimes.com/view/research-suggests-course-of-diabetic-eye-disease-influenced-by-genetic-factors 2020-11-30 0.50 https://www.ophthalmologytimes.com/view/identifying-gaps-in-anti-vegf-treatment-among-minorities-with-dme 2020-11-30 0.50 https://www.ophthalmologytimes.com/view/challenges-to-diabetes-management 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/treatment-options-for-dr-dme 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/ada-guidelines-for-dr-dme-management 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/diabetes-management-communication-between-ods-and-mds 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/optimizing-diabetes-health-management 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/use-of-oct-a-for-patients-with-diabetes 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/imaging-for-diabetic-retinopathy 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/overview-of-diabetic-eye-disease 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/integrating-ai-manage-dr-in-a-primary-care-setting 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/updates-in-dme-diabetic-retinopathy 2021-08-09 0.50 https://www.ophthalmologytimes.com/view/aao-2020-comparing-outcomes-of-xen-gel-stents-in-glaucoma-practice 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/women-less-likely-than-men-to-receive-retinal-detachment-repair 2020-11-23 0.50 https://www.ophthalmologytimes.com/view/schepens-lecturer-russell-van-gelder-md-phd-could-small-molecule-photoswitches-be-the-miracle-of-vision-restoration- 2020-11-23 0.50 https://www.ophthalmologytimes.com/view/final-thoughts-on-the-progression-of-treatment-for-wet-amd 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/the-use-of-telemedicine-for-wet-amd-treatment 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/the-impact-of-covid-19-on-the-management-of-wet-amd 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/compounds-and-home-monitoring-device-in-development-for-wet-amd 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/role-of-biosimilars-in-management-of-wet-amd 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/safety-concerns-with-anti-vegf-agents-for-wet-amd 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/reasons-for-switching-between-agents-for-wet-amd 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/personal-experience-with-anti-vegf-agents-for-wet-amd 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/anti-vegf-agents-for-treatment-of-wet-amd 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/clinical-trials-vs-real-world-data-on-wet-amd 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/identifying-a-typical-patient-with-wet-amd 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/introduction-and-definition-of-macular-degeneration 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/aao-2020-study-outlines-use-of-injectable-intraocular-steroid-over-drops 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/aao-2020-fingolimod-for-ms-offers-disease-control-with-no-development-of-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-drop-free-prophylaxis-regimen-before-cataract-surgery-lowers-treatment-burden-with-caveats 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-preventing-cystoid-macular-oedema-after-cataract-surgery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-alcon-showcases-advanced-iol-technology-for-presbyopia 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-medication-could-reduce-burden-of-steroid-drops-for-patients 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/aao-2020-alimera-highlights-new-day-study-for-sustained-release-intravitreal-implant 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/aao-2020-headache-paired-with-visual-loss-may-require-honing-of-detective-skills 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-autologous-retinal-transplant-for-larger-macular-holes-gaining-traction 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-myopia-progression-slowed-with-orthok-multifocal-lenses 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/considerations-when-using-anti-vegf-for-treating-amd 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/aao-2020-heidelberg-imaging-platforms-poised-for-future-of-ophthalmology 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-alcon-virtual-booth-spotlights-latest-studies-retina-product-offerings 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/aao-2020-study-confirms-phase-iii-results-for-uveitis-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-applying-impact-of-real-world-data-on-day-to-day-practice 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-gene-therapy-for-x-linked-retinitis-pigmentosa-achieves-significant-visual-gains-at-1-year 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/aao-2020-micro-vacuum-pick-for-use-during-vitreoretinal-surgery-proving-to-be-a-better-mousetrap 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/aao-2020-intravitreal-anti-vegf-injections-for-exudative-ram-an-alternative-to-laser 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-how-not-to-be-afraid-of-performing-a-posterior-capsulorhexis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-genentech-provides-update-on-presentations-product-portfolio 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2020-bringing-high-level-content-to-a-virtual-audience 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ucsf-ophthalmology-programs-now-under-one-roof 2020-11-11 0.50 https://www.ophthalmologytimes.com/view/announcing-the-ophthalmology-times-research-scholar-honoree-top-5-finalists-for-2020 2024-04-25 0.50 https://www.ophthalmologytimes.com/view/what-to-expect-from-virtual-aao-2020-eyepod 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ksi-301-for-exudative-retinal-disease-showing-safety-efficacy-and-durability 2020-11-06 0.50 https://www.ophthalmologytimes.com/view/exploring-pathogenic-cytokines-as-biomarkers-for-dme 2020-11-03 0.50 https://www.ophthalmologytimes.com/view/choosing-a-syringe-for-intravitreal-injection 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aflibercept-broadly-effective-for-reducing-dr-severity-in-post-hoc-analysis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/improving-measurable-visual-outcomes-with-dietary-supplementation 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-examines-silicone-rubber-balloon-scleral-buckling-for-rrds 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/investigators-make-case-for-postop-faceup-positioning-for-rdds-with-inferior-retinal-breaks 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/serpico-10-study-focuses-on-the-impact-of-covid-19-on-retina 2020-10-21 0.50 https://www.ophthalmologytimes.com/view/spotlighting-telemedicine-in-the-year-of-a-pandemic 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/laser-treatment-observation-for-dme-could-save-u-s-healthcare-system-billions 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/cooling-anesthesia-a-safe-effective-alternative-to-subconjunctival-lidocaine 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/imaging-retinal-pathologies-can-be-challenging-with-current-technologies 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retina-in-2020-and-beyond 2022-01-05 0.50 https://www.ophthalmologytimes.com/view/asrs-study-analyzes-the-opioid-prescription-patterns-of-u-s-retina-specialists 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pearls-for-maintaining-quality-safety-in-retina-clinics-amid-a-pandemic 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/zeiss-concentrates-workflow-enhancements-euretina-2020 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/oculus-prioritizing-production-during-pandemic-euretina-2020 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/speakers-to-present-challenging-cases-euretina-2020 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/infiltrative-optic-neuropathy-in-a-patient-with-esophageal-adenocarcinoma 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/neovascular-amd-has-substantial-psychological-impact-on-patients 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/heidelberg-dynamic-visualization-whole-eye-euretina-2020 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/geuder-introduces-new-products-euretina-2020 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/novel-retinal-technologies-imaging-disease-management-euretina-2020 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/casting-light-on-diabetic-eye-disease-better-understanding-key-to-prevention 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/port-delivery-system-with-ranibizumab-maintenance-of-vision-with-reduced-treatment-burden 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/oertli-introduces-new-products-euretina-2020 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/developments-in-store-at-the-virtual-euretina-2020 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/heads-up-surgery-more-options-for-better-outcomes 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/nr600-retinal-prosthesis-safe-with-promising-visual-results 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/bayer-discusses-relevant-clinical-study-results-euretina-2020 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/researchers-advocate-for-intraoperative-intravitreal-steroid-during-cataract-surgery-in-dme-eyes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/implementing-at-home-monitoring-for-exudative-amd 2020-10-08 0.50 https://www.ophthalmologytimes.com/view/study-associates-frequent-anti-vegf-injections-with-risk-of-mild-cognitive-impairment 2020-10-08 0.50 https://www.ophthalmologytimes.com/view/probe-of-iris-registry-shows-anti-vegf-injections-leading-treatment-for-pdr 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/same-day-exams-with-anti-vegf-therapy-key-to-qol-cost-savings-for-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/mips-is-meant-to-encourage-quality-care-but-is-it-preventing-it- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/easing-patient-comfort-pain-perception-of-intravitreal-injections 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/taking-a-deeper-dive-novel-gene-therapy-approaches-to-treat-ocular-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/robotics-allow-surgeons-to-perform-the-seemingly-impossible 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/bausch-health-to-acquire-option-to-purchase-ophthalmology-assets-of-allegro 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/big-data-driving-opportunity-for-real-world-evidence 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/surgical-pearls-for-staying-sharp-during-the-covid-19-pandemic 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/harnessing-regeneration-of-retinal-tissues-an-option-almost-within-reach 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/persistent-retinal-detachment-associated-with-retinoblastoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/targeting-amd-patient-treatment-burden 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/novartis-positive-dme-data-for-brolucizumab-in-kite-trial 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/octa-why-the-jury-may-still-be-out 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/regenxbio-dosing-of-first-patient-in-phase-2-aaviate-trial-for-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fa-implant-outperforms-anti-vegf-in-dr-patients-lost-to-follow-up 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/deep-learning-algorithm-proving-accurate-for-amd-classification 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/managing-the-challenge-of-cataract-surgery-in-eyes-with-diabetic-macular-edema 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/contrast-sensitivity-shows-potential-for-measuring-visual-function-loss-in-early-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/identifying-biomarkers-to-predict-diabetic-retinopathy-progression 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/future-of-ophthalmology-part-iii 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retina-innovations-amid-pandemic-eyepod 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/improving-visual-outcomes-after-360-relaxing-retinectomy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/what-photobiomodulation-may-mean-for-patients-with-dry-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-allows-expanded-use-of-convalescent-plasma-as-potential-covid-19-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/implementing-adapting-to-protocol-changes-for-clinical-practice 2020-08-21 0.50 https://www.ophthalmologytimes.com/view/what-keeps-you-up-at-night-in-ophthalmology 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/future-of-ophthalmology-part-ii-vision-2020 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/what-is-the-future-of-ophthalmology-part-1 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/looking-to-the-future-in-retina-innovations 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/stem-cells-dry-amd-ga-show-promise-in-early-study 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/amd-ded-most-common-retinal-conditions-in-us 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-grants-fourth-odd-for-treatment-of-pde6b-gene-mutation-associated-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/clinical-trial-outcomes-macular-edema-dont-translate-to-real-world 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/3-year-recurrence-rate-non-infectious-posterior-segment-veitis-post-fai 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/vista-subanalysis-macular-rnp-clinical-outcomes 2020-08-13 0.50 https://www.ophthalmologytimes.com/view/investigators-asymptomatic-covid-19-patients-may-have-left-viral-material-on-surfaces-of 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/early-detection-cnv-second-eye-key-to-improving-outcomes 2020-08-07 0.50 https://www.ophthalmologytimes.com/view/efficacy-and-safety-of-intravitreal-aflibercept-eylea-r-therapy-using-a-proactive-treat-and 2020-08-10 0.50 https://www.ophthalmologytimes.com/view/bausch-health-spin-off-of-eye-health-business 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-baseline-oct-risuteganib-intermediate-amd-treatment 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-dexamethasone-intracameral-vitreoretinal-inflammation 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-surgeon-integrating-retina-advances-covid-19 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-dr-progression-anti-vegf-versus-fa-implant 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/characterizing-localized-retinal-layer-changes-in-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/vision-related-quality-of-life-impacts-of-advanced-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-explores-mental-health-issues-in-patients-with-diabetic-retinopathy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/considering-ethnicity-related-differences-in-macular-thickness-among-diabetics 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-asclepix-lead-candidate-potential-for-wet-amd-dme-rvo 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-aviceda-avd-104-may-mean-for-dry-amd 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-eyepod-evaluating-3-year-recurrence-rate-post-fai 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-alcon-showcases-latest-retina-innovations-data 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-pds-with-ranibizumab-signals-paradigm-shift-in-treatment-of-neovascular-amd 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-protocol-t-extension-study-shows-long-term-visual-declines-in-dme-eyes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-trial-shows-faricimab-blocks-ang-2-and-vegf-a 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-augmented-reality-headset-provides-vision-for-amd-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-intravitreal-liposome-encapsulated-bromfenac-offers-promise-as-treatment-for 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-2020-imaging-modalities-offering-bold-noninvasive-monitoring 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ss-oct-ss-octa-provide-useful-findings-in-active-ocular-toxoplasmosis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/evaluating-the-change-in-va-cmt-after-early-switch-of-anti-vegf-drugs 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/bowtie-artifacts-clinical-biomarkers-for-center-involving-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/clinical-trials-in-the-covid-19-era 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/telemedicine 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/artificial-intelligence-ai-and-retina 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/coming-down-the-pike 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/treatment-burden 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/improved-durability 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/treating-the-whole-patient-when-to-switch-and-why 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/real-world-experiences-and-clinical-trials-why-outcomes-differ 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/treatment-strategies-during-a-pandemic 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/the-advent-of-the-anti-vascular-endothelial-growth-factor-vegf-treatment-regimen 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/intro 2021-06-23 0.50 https://www.ophthalmologytimes.com/view/intravitreal-gene-therapy-holds-promise-for-novel-wet-amd-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ocriplasmin-clinically-meaningful-increases-in-visual-function-in-symptomatic-vitreomacular 2020-07-17 0.50 https://www.ophthalmologytimes.com/view/ilm-peeling-prevents-development-of-erms 2020-07-15 0.50 https://www.ophthalmologytimes.com/view/faf-sheds-light-on-patterns-related-to-disease-chronicity-in-csc 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/anti-vegf-therapy-may-prevent-delay-radiation-maculopathy-in-choroidal-melanoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ultra-widefield-imaging-can-enhance-efficiency-for-practices 2020-07-10 0.50 https://www.ophthalmologytimes.com/view/company-seeks-first-fda-approved-ophthalmic-formulation-of-bevacizumab-for-use-in-retinal 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/noninfectious-uveitis-meeting-the-challenge 2020-07-08 0.50 https://www.ophthalmologytimes.com/view/improving-patient-comfort-with-intravitreal-injections 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/antihyperglycemic-drug-associated-with-reduced-risk-of-new-onset-amd 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/identifying-risk-factors-for-severe-diabetic-eye-disease 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/new-protocol-v-findings-offer-guidance-for-managing-dme 2020-07-08 0.50 https://www.ophthalmologytimes.com/view/face-down-positioning-better-after-detached-retina-repair 2020-06-29 0.50 https://www.ophthalmologytimes.com/view/subretinal-gene-therapy-safe-with-visual-benefit 2020-07-07 0.50 https://www.ophthalmologytimes.com/view/st-laser-therapy-may-reduce-dme-intravitreal-injections 2020-06-22 0.50 https://www.ophthalmologytimes.com/view/turning-new-frontier-micropulse-laser-treatment-retinal-disorders 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/role-human-amniotic-membrane-surgery-recurrent-macular-holes 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/covid-19-how-orbis-international-managing-operations-0 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/how-dme-patients-may-fare-differently-real-world-versus-trials 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/screening-dr-tele-ophthalmology-ai-less-expensive-human-assessment 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/determining-risk-ocular-damage-chronic-intravitreal-injections 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/pack-cxl-researchers-continue-clear-hurdles-topical-drugs-0 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/echoes-history-covid-19-pandemic-stirs-memories-tests-our-mettle 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/technology-perfect-pediatric-neuro-ophthalmology-diagnoses-0 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/researchers-find-low-risk-covid-19-transmission-tears 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/pharmacologic-treatment-option-open-angle-glaucoma-1 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/covid-19-how-neuro-ophthalmology-acclimating-pandemic-era-0 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/coronavirus-response-generations-react-differently-covid-19-0 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/covid-19-tips-protecting-patientsstaff-0 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/why-timing-everything-amd 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/covid-19-putting-safety-measures-practice-0 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/covid-19-impact-pandemic-switzerlands-ophthalmic-space-1 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/what-retinal-specialists-should-know-about-their-pregnant-patients 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/covid-19-keeping-staff-and-patients-safe-during-pandemic-1 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-autonomous-diagnostics-dr-gave-jump-start-ai-ophthalmology 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/covid-19-life-time-coronavirus 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/covid-19-how-eyecare-professionals-are-taking-precautions-0 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/subthreshold-laser-may-reduce-intravitreal-injections-dme 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/iris-registry-study-overall-anti-vegf-injection-intervals-wet-amd-similar-1-2-years 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/amd-awareness-close-focus-preserving-vision 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/prn-ranibizumab-outcomes-over-long-term-real-world 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/consensus-group-redefines-standardizes-amd-classifications 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/diagnosing-amd-non-retina-specialist 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/stem-cell-transplantation-restoring-vision-amd-may-be-possible 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/exploring-safety-stem-cells-dry-amd 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/what-non-retina-specialists-need-know-about-dry-amd 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/connect-dots-diagnosing-managing-multifocal-choroiditides-0 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/amd-what-newly-diagnosed-patients-need-know 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/researchers-identify-biomarkers-selecting-amd-patients-tes-protocol 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/coming-terms-ultra-widefield-and-widefield-imaging 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/research-targets-gene-therapy-exudative-amd-patients 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/deep-learning-future-diabetic-retinopathy-screening 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/tracking-anti-vegf-use-among-medicare-part-b-beneficiaries 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/early-intervention-best-patients-diabetic-eye-diseases 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/patient-assistance-programs-available-patients-dme 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/myopia-may-prove-beneficial-preventing-dr-development 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/ultra-widefield-oct-may-be-only-imaging-needed-manage-pdr 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/guidelines-treating-diabetic-eye-patient 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/anti-vegf-injections-and-glaucoma-surgeons-must-watch-iop-elevation 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/risk-factors-and-recommendations-dr-dme 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/central-subfield-thickness-only-partially-responsible-changes-acuity 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/amd-risk-phenotypes-targeted-direct-consumer-genetic-database 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/ai-model-predicts-future-dr-progression-individual-patients 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/aao-2019-single-session-devoted-diabetes 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/raising-awareness-diabetic-eye-disease 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/sustained-drss-improvement-aflibercept 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/several-cyst-characteristics-linked-ischemia-dme 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-dr-rishi-singh 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-josh-anderson 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/swap-two-shows-anatomic-improvement-after-switch-aflibercept 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-chuck-hess 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-w-lloyd-clark-md 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-rishi-p-singh-md 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-charles-c-wykoff-md-phd 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/meta-analysis-dme-treatments-updated-include-treatment-regimen 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-raj-k-maturi-md 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/anti-vegfs-pose-no-additional-risk-saes-over-other-therapies 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/fish-focus-fast-eye-infection-diagnosis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/us-international-physicians-mostly-agreement-over-treatment-practices 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/global-trends-show-similar-patterns-worldwide 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/retina-risk-app-tool-empowers-diabetic-patients-worldwide 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-john-t-thompson-md 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-josh-mali-md 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/migraines-and-retinal-perfusion-headache-physicians-patients 2021-09-29 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-netan-choudhry-md-frcsc-dabo 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-justis-p-ehlers-md 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2019-street-team-david-s-boyer-md 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/intraoperative-surgical-methods-hold-key-amd-treatment 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/obesity-diabetic-retinopathy-korean-study-explores-inverse-association 2021-09-23 0.50 https://www.ophthalmologytimes.com/view/dna-analysis-unraveling-role-genetics-dr-pathogenesis 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/lipid-lowering-drugs-lower-dr-risk-may-go-hand-hand 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/anti-vegf-expansion-treats-all-dr-stages 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/intravenous-prostaglandin-e1-infusion-acute-central-retinal-artery-occlusion 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/laser-treatment-dme-still-place-table 2021-09-23 0.50 https://www.ophthalmologytimes.com/view/mini-quiz-educating-patients-about-dme 2023-02-28 0.50 https://www.ophthalmologytimes.com/view/determining-dr-progression-much-work-still-needs-be-done 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/look-clues-simplify-anterior-uveitis-diagnosis 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/image-reading-accuracy-increases-deep-learning-dr-algorithms 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/arvo-heads-north-vancouver-2019-annual-meeting 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/lasers-place-diabetic-retinopathy-choosing-right-scenario 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/successful-pdr-outcomes-driven-strict-adherence-follow 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/ongoing-study-evaluates-sirolimus-therapeutic-option-uveitis 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/read-through-gene-therapies-lca-showing-promise 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/biologics-may-offer-systemic-therapy-option-uveitis 2023-08-31 0.50 https://www.ophthalmologytimes.com/view/adalimumab-efficacious-uveitis-regardless-disease-duration 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/sustained-release-corticosteroid-expands-armamentarium-uveitis 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/tocilizumab-effective-managing-posterior-segment-inflammation 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/managing-uveitic-macular-edema 2021-07-12 0.50 https://www.ophthalmologytimes.com/view/understanding-etiology-crucial-appropriate-uveitic-treatment 2021-07-12 0.50 https://www.ophthalmologytimes.com/view/cataract-surgery-patients-diabetes-no-time-present 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/programs-provide-patient-assistance-amd-treatments 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/whats-wet-amd-pipeline 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/icymi-state-amd-research-2018 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/pipeline-dry-amd-holds-promise 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/arming-amd-patients-knowledge 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/talking-about-genetics-and-amd 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/uwf-imaging-contributes-earlier-disease-detection 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/applying-ai-fundus-images 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/celebrating-retina-research-future-generation-eyemds 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/what-newly-diagnosed-amd-patients-need-know 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/tgf-signaling-governs-immune-cell-function-eye 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/decreasing-burden-namd-therapy 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/real-world-study-fluocinolone-acetonide-implant-show-its-benefits-treating-dme 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/il-6-inhibition-shows-promise-treatment-non-infectious-uveitis 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/novel-treatments-pipeline-diabetic-eye-disease 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/when-vitrectomy-offers-viable-therapeutic-option-dme 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/data-promising-uveitic-macular-edema-pivotal-trial 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/patient-assistance-programs-can-ease-dme-financial-burden 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/minute-diabetic-updates-your-patients 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/alternative-dosing-regimens-increase-compliance-dme 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/anatomic-outcome-more-precise-defining-dme-treatment-failure 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/lessons-learned-drcrnet-protocols 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/diabetic-eye-disease-best-treatment-options-your-patients 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/laser-therapy-may-offer-fast-acting-option-csr-resolution 2021-01-18 0.50 https://www.ophthalmologytimes.com/view/november-diabetic-eye-disease-awareness-month-0 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/dme-what-it-and-how-treat-it 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/targeting-angiopoietin-2-vegf-treat-dme 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/intestinal-microbiome-proposed-potential-therapeutic-target-amd 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/nanotechnology-strategies-explored-novel-therapeutic-approach-photoreceptor-blindness 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/refillable-implant-releasing-ranibizumab-phase-iii-study 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/schepens-lecturer-shares-ideas-moving-forward-amd 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/three-pearls-uveitis-diagnosis 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/success-retinal-detachment-surgery-depends-using-right-strategies 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/novel-therapies-could-stem-burden-diabetic-eye-disease 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/commercial-cell-therapy-clinics-yield-little-evidence 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/imaging-and-retinal-disorders 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/subthreshold-lasers-role-retinal-vascular-disease 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/study-shows-alzheimers-disease-biomarkers-vitreous 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/understanding-variances-hypersonic-vitrector-settings 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/octa-may-be-harbinger-anti-vegf-efficacy 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/anti-vegfs-can-improve-drss-majority-patients 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/progression-surgery-erms-good-vision 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/achromatopsia-understanding-rare-inherited-retinal-disease 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/risuteganib-treatment-dme 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/light-induced-visual-response-objective-functional-vision-testing 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/ceo-aerie-pharmaceuticals-provides-brief-company-overview-ois-meeting 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/incorporating-office-based-electrophysiology-everyday-practice 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/diabetic-eye-disease-advances-questions-remain 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/microaneurysm-turnover-predicts-diabetic-retinopathy-progression 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/two-drugs-better-one-dme-therapy 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/parafoveal-retinal-vessel-density-assessment-octa-healthy-eyes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/global-trends-retina-how-surgeons-are-practicing-2018 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/oral-therapy-may-be-viable-csc 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/fellows-report-increasing-surgical-experience-during-training 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/why-microscope-integrated-oct-vital-gene-therapy 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/numerous-advances-diabetic-eye-disease-many-questions-remain 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/what-makes-pneumatic-vitreolysis-highly-effective-vmt 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/what-apl-2-means-geographic-atrophy 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/how-amd-patients-are-treated-real-world 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/brolucizumab-next-generation-anti-vegf-therapy 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/how-updated-ico-guidelines-impact-patients-diabetic-eye-care 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/peripheral-retinal-drusen-more-common-alzheimers 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/when-and-how-treat-myopic-traction-maculopathy 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/thermoresponsive-microspears-may-minimize-surgical-infections 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/real-world-effect-intravitreous-anti-vegf-drugs-iop-analysis-using-iris-registry 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/dendritic-cells-migrate-regions-retinal-stress-mediate-neurodegeneration 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/review-epidemiology-diabetic-retinopathy 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/new-name-old-problem 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/cutters-or-scissors-pdr 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/role-oxidative-stress-dme 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/steroid-therapy-dme-yes-or-maybe 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/spectrum-central-serous-retinopathy 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/how-fame-data-may-assist-dme-treatment-decisions 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/safe-dosing-hcq-dependent-body-type 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/suprachoroidal-space-promising-route-retinal-drug-delivery 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/modern-medicine-feature-adalimumab-therapy-safe-effective-real-world-open-label-uveitis-study 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/pearls-better-uveitis-workups 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/how-dr-progresses-type-1-diabetes 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/octa-provides-better-view-acute-anterior-uveitis 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/making-strides-uveitis-therapy 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/defining-terms-origins-type-3-nv 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/retrospective-study-characterizes-success-retinal-detachment-surgery-large-cohorts 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/modern-medicine-feature-improving-accuracy-and-comfort-intravitreal-injections 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/plasma-free-vegf-level-decreases-aflibercept-bevacizumab 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/wider-field-view-does-improve-visualization-retinal-vascular-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/macular-degeneration-patients-regain-sight-stem-cell-implants 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/failed-lampalizumab-studies-offer-numerous-lessons-about-ga 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/time-has-come-gene-therapy-treat-retinal-disease-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/paladin-subset-finds-improvement-after-12-months-intravitreal-implant 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/does-dexamethasone-implant-add-benefit-ranibizumab-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/distinction-between-lamellar-holes-and-macular-pseudoholes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/hypersonic-vitrectomy-overcomes-flaws-traditional-systems 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aflibercept-shows-macular-perfusion-gains-vista-subanalysis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/amd-trial-data-are-highlights-recent-conferences 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/patient-assistance-programs-amd-treatments 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/moorfields-research-provides-hope-choroideremia-cure-1 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/intravitreal-implant-could-bring-significant-cost-savings-nhs-england 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/apl-2-slows-growth-ga-phase-ii-safety-and-efficacy-trial 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sequenced-approach-offers-effective-retinectomy-less-complications 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/latest-research-brings-awareness-new-amd-discoveries 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/resolve-patient-confusion-amd-awareness-understanding 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/these-novel-strategies-may-change-dme-treatment-paradigm 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/most-talked-about-journal-articles-bring-awareness-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-practice-patterns-offers-awareness-proper-amd-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/extensive-analysis-confirms-treat-and-extend-regimens-reliable-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-approval-retinal-dystrophy-drug-launches-era-ocular-gene-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/systematic-review-brings-awareness-treat-and-extend-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/are-you-aware-available-resources-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/honors-celebrate-research-future-generation-retina 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/partner-perspective-patient-case-study-continuous-microdosing-treatment-iluvien-fluocinolone 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/research-offers-insights-clinical-course-management-cscr 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/video-system-has-transformative-potential-blind-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/treat-and-extend-protocol-reduces-burden-anti-vegf-treatment-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/suprachoroidal-corticosteroid-shows-visual-anatomic-improvements-dme-eyes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/data-demonstrate-real-world-benefits-fluocinolone-acetonide-implant 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/telemedicine-making-rop-screening-and-monitoring-viable-reality 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/electroretinography-out-laboratory-and-clinic 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/diagnosing-early-stage-amd-dark-adaptation-device 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/algorithms-provide-guidance-managing-rvo-related-macular-edema 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-finds-no-va-benefit-adding-corticosteroid-implant-anti-vegf-injections 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ultra-widefield-angiography-new-window-retinovascular-features 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/contrast-sensitivity-device-exposes-vision-limitations-reattachment-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/greater-subfoveal-choroidal-thickness-amd-eyes-more-injections-needed 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/topical-squalamine-offers-novel-promising-therapy-namd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/chandelier-assisted-technique-shines-improving-scleral-buckling 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/endoscope-offers-versatility-over-microscope-retinal-surgeries 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/2017-mixed-bag-retina-specialists 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/awards-recognize-long-standing-leaders-retina 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/2017-will-shape-how-we-treat-patients-future 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/isopropyl-nitrate-poppers-pose-maculopathy-risk 2021-01-18 0.50 https://www.ophthalmologytimes.com/view/retina-subspecialty-day-year-review-and-amd 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/is-have-it-what-imaging-now-able-tell-us 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/30-must-see-tweets-aao-2017 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/new-hero-vegf-fight 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/protocol-u-u 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/long-term-trends-ophthalmology 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/vitrectomy-brachytherapy-shows-no-increase-metastatic-risk 2020-11-14 0.50